These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7966159)

  • 1. Chemical and biological evaluation of hydrolysis products of cyclophosphamide.
    Gilard V; Martino R; Malet-Martino MC; Kutscher B; Müller A; Niemeyer U; Pohl J; Polymeropoulos EE
    J Med Chem; 1994 Nov; 37(23):3986-93. PubMed ID: 7966159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical stability and fate of the cytostatic drug ifosfamide and its N-dechloroethylated metabolites in acidic aqueous solutions.
    Gilard V; Martino R; Malet-Martino M; Niemeyer U; Pohl J
    J Med Chem; 1999 Jul; 42(14):2542-60. PubMed ID: 10411475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of new aqueous chemical degradation products of isophosphoramide mustard.
    Breil S; Martino R; Gilard V; Malet-Martino M; Niemeyer U
    J Pharm Biomed Anal; 2001 Jun; 25(3-4):669-78. PubMed ID: 11377048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antitumor activity of cyclophosphamide analogues. 4. Preparation, kinetic studies, and anticancer screening of "phenylketophosphamide" and similar compounds related to the cyclophosphamide metabolite aldophosphamide.
    Ludeman SM; Boyd VL; Regan JB; Gallo KA; Zon G; Ishii K
    J Med Chem; 1986 May; 29(5):716-27. PubMed ID: 3701785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antitumor properties of activated cyclophosphamide analogues.
    Borch RF; Canute GW
    J Med Chem; 1991 Oct; 34(10):3044-52. PubMed ID: 1920355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo antitumor activity and in vitro cytotoxic properties of bis[1,2-bis(diphenylphosphino)ethane]gold(I) chloride.
    Berners-Price SJ; Mirabelli CK; Johnson RK; Mattern MR; McCabe FL; Faucette LF; Sung CM; Mong SM; Sadler PJ; Crooke ST
    Cancer Res; 1986 Nov; 46(11):5486-93. PubMed ID: 3756897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical stability of pentostatin (NSC-218321), a cytotoxic and immunosuppressant agent.
    al-Razzak LA; Benedetti AE; Waugh WN; Stella VJ
    Pharm Res; 1990 May; 7(5):452-60. PubMed ID: 2367313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of monomeric and polymeric cyclophosphamide derivatives compared with in vitro hydrolysis.
    Hirano T; Ringsdorf H; Zaharko DS
    Cancer Res; 1980 Jul; 40(7):2263-7. PubMed ID: 7388792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of reactive metabolite-analogues of cyclophosphamide for comparisons of NMR kinetic parameters and anticancer screening data.
    Ludeman SM; Boyd VL; Regan JB; Gallo KA; Zon G; Ishii K
    Drugs Exp Clin Res; 1986; 12(6-7):527-32. PubMed ID: 3743371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mechanistic and kinetic study of the beta-lactone hydrolysis of Salinosporamide A (NPI-0052), a novel proteasome inhibitor.
    Denora N; Potts BC; Stella VJ
    J Pharm Sci; 2007 Aug; 96(8):2037-47. PubMed ID: 17554770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adriamycin analogues. rationale, synthesis, and preliminary antitumor evaluation of highly active DNA-nonbinding N-(trifluoroacetyl)adriamycin 14-O-hemiester derivatives.
    Israel M; Potti PG; Seshadri R
    J Med Chem; 1985 Sep; 28(9):1223-8. PubMed ID: 3839851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biotransformation of mafosfamide in P388 mice leukemia cells: intracellular 31P-NMR studies.
    Sonawat HM; Leibfritz D; Engel J; Hilgard P
    Biochim Biophys Acta; 1990 Apr; 1052(1):36-41. PubMed ID: 2322593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrolytic pathway of 5-fluorouracil in aqueous solutions for clinical use.
    Legay R; Massou S; Azéma J; Martino R; Malet-Martino M
    J Pharm Biomed Anal; 2014 Sep; 98():446-62. PubMed ID: 25038499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of the cytotoxic action of mafosfamide by N-isopropyl-p-formylbenzamide, a metabolite of procarbazine.
    Maki PA; Sladek NE
    Cancer Res; 1991 Aug; 51(16):4170-5. PubMed ID: 1868438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epimer interconversion, isomerization, and hydrolysis of tetrahydrouridine: implications for cytidine deaminase inhibition.
    Xiang TX; Niemi R; Bummer P; Anderson BD
    J Pharm Sci; 2003 Oct; 92(10):2027-39. PubMed ID: 14502542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of the hydrolysis of guanosine 5'-phospho-2-methylimidazolide.
    Kanavarioti A
    Orig Life Evol Biosph; 1986; 17(1):85-103. PubMed ID: 11536569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collateral sensitivity to cross-linking agents exhibited by cultured L1210 cells resistant to oxazaphosphorines.
    Sladek NE; Low JE; Landkamer GJ
    Cancer Res; 1985 Feb; 45(2):625-9. PubMed ID: 3967238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated decomposition of 4-hydroxycyclophosphamide by human serum albumin.
    Kwon CH; Maddison K; LoCastro L; Borch RF
    Cancer Res; 1987 Mar; 47(6):1505-8. PubMed ID: 3815352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-(beta-Arylvinyl)-3-(beta-arylvinylketo)-1-ethyl-4-piperidinols and related compounds: a novel class of cytotoxic and anticancer agents.
    Dimmock JR; Vashishtha SC; Quail JW; Pugazhenthi U; Zimpel Z; Sudom AM; Allen TM; Kao GY; Balzarini J; De Clercq E
    J Med Chem; 1998 Oct; 41(21):4012-20. PubMed ID: 9767639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical characterization of ASTA Z 7557 (INN mafosfamide, CIS-4-sulfoethylthio-cyclophosphamide), a stable derivative of 4-hydroxy-cyclophosphamide.
    Niemeyer U; Engel J; Scheffler G; Molge K; Sauerbier D; Weigert W
    Invest New Drugs; 1984; 2(2):133-9. PubMed ID: 6469506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.